| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.607 | 2.858 | 8.815 | 4.934 | 5.312 | 8.545 |
| Total Income - EUR | - | - | - | - | 3.607 | 4.615 | 8.815 | 4.934 | 5.313 | 8.545 |
| Total Expenses - EUR | - | - | - | - | 3.198 | 4.365 | 8.411 | 6.847 | 3.694 | 7.649 |
| Gross Profit/Loss - EUR | - | - | - | - | 410 | 250 | 403 | -1.913 | 1.620 | 896 |
| Net Profit/Loss - EUR | - | - | - | - | 302 | 165 | 171 | -2.061 | 1.211 | 288 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Stopcancer S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 63 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 2.190 | 759 | 2.577 | 1.214 | 2.313 | 3.028 |
| Inventories | - | - | - | - | 443 | 0 | 0 | 0 | 0 | 60 |
| Receivables | - | - | - | - | 774 | 440 | 1.732 | 0 | 927 | 921 |
| Cash | - | - | - | - | 974 | 320 | 845 | 1.214 | 1.387 | 2.047 |
| Shareholders Funds | - | - | - | - | 344 | 502 | 661 | -1.398 | -182 | 106 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.910 | 258 | 1.916 | 2.612 | 2.510 | 2.922 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Stopcancer S.r.l.